GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity
Mark D Bunting, Antiopi Varelias, Fernando Souza-Fonseca-Guimaraes, Iona S Schuster, Katie E Lineburg, Rachel D Kuns, Peter Fleming, Kelly R Locke, Nicholas D Huntington, Bruce R Blazar, Steven W Lane, Siok-Keen Tey, Kelli PA MacDonald, Mark J Smyth, Mariapia A Degli-Esposti, Geoffrey R Hill
Blood | AMER SOC HEMATOLOGY | Published : 2017
Awarded by National Institutes of Health National Cancer Institute
This work was supported by research grants from the National Health and Medical Research Council (NH&MRC). F.S.-F.-G. was supported by a NH&MRC Early Career Research Fellowship and National Breast Cancer Foundation Fellowship. S.W.L. was supported by a NH&MRC Career Development Fellowship. M.A.D.-E. was a NH&MRC Principal Research Fellow. M.J.S. and G.R.H. were NH&MRC Senior Principal Research Fellows. G.R.H. was a QLD Health Senior Clinical Research Fellow. B.R.B. was supported by National Institutes of Health National Cancer Institute grant R01 CA72669.